Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
Document › Details

Carbios S.A.. (1/7/16). "Press Release: Report on Carbios’ Liquidity Contract with Invest Securities". Clermont-Ferrand.

Organisations Organisation Carbios S.A. (Euronext Growth Paris: ALCRB)
  Organisation 2 Invest Securities S.A.
Products Product industrial biotechnology
  Product 2 financial services
Persons Person Audebert, Benjamin (Carbios 201601 Investor Relations)
  Person 2 Carmagnol, Caroline (Alize RP 201107 CEO + Founder)
     


CARBIOS (Alternext Paris : ALCRB), an innovative green chemistry company specializing in breakthrough technologies dedicated to the recovery of plastic waste and the production of bio-polymers, reports today about the liquidity contract entrusted to the brokerage firm Invest Securities.

As of 31 December 2015, the following assets appeared on the liquidity account:

- Number of shares: 10 123

- Cash balance of the liquidity account: €32,761.35


For the record, as of the half-year report on 30 June 2015, the following assets appeared on the liquidity account:

- Number of shares: 8,432

- Cash balance of the liquidity account: €50,000.65


About CARBIOS:

CARBIOS is a young, innovative green chemistry company, whose mission is to find biological solutions to the environmental and sustainable development issues faced by industrial businesses today. CARBIOS acquired the rights to research that was conducted over a number of years by various public and private sector laboratories. By leveraging the unique properties of biological catalysts (enzymes), it has used this research as the foundation for developing innovative industrial bioprocesses that optimize the technical, economic and environmental performance of polymers (thermoplastic materials and synthetic or food-based fibers). The company has focused its efforts on a strategic application sector: plastics. CARBIOS’ growth strategy is based on a clear business model of industrial value creation that targets attractive markets, develops innovative and competitive bioprocesses and licenses them to major industrial stakeholders for commercialization. CARBIOS benefits from the financial support of the leading European venture capital firm Truffle Capital. CARBIOS was founded in 2011 and has been funded, since its inception, by funds managed by the Holding Incubatrice Chimie Verte fund. CARBIOS was granted the label “Young Innovative Company” by Bpifrance (former OSEO) and is eligible for investments by private equity mutual funds (FCPIs).

For more information, please visit www.carbios.fr


CARBIOS is eligible for the PEA-PME, a government program allowing French residents investing in SMEs to benefit from income tax rebates.


Contacts :

CARBIOS
Benjamin Audebert
Investor Relations
+33 (0)4 73 86 51 76
contact@carbios.fr

ALIZE RP
Caroline Carmagnol / Wendy Rigal
Press Relations
+33 (0)1 44 54 36 66 / +33 (0)6 48 82 18 94
carbios@alizerp.com

Published on 07.01.2016

   
Record changed: 2018-12-04

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Carbios S.A. (Euronext Growth Paris: ALCRB)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px




» top